Roger Franklin
Direktor/Vorstandsmitglied bei ABLIVA AB
Ursprung des Netzwerks ersten Grades von Roger Franklin
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Liberum Capital Ltd.
 Liberum Capital Ltd. Investment Banks/BrokersFinance Liberum Capital Ltd. (Liberum) is the Great Britain-based brokerage subsidiary of TN Holdings (BVI) Ltd. in British Virgin Islands. The firm was founded in 2007 by Shane Le Prevost. Headquartered in London, Liberum provides trading and execution services for institutional clients. They bring liquidity into the niches that matter and are market-makers in more than 350 large, mid and small-cap stocks.
132
| Subsidiary | Investment Banks/Brokers | 132 |
13
| Public Company | Pharmaceuticals: Major | 13 |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Hadean Ventures AS
 Hadean Ventures AS Investment ManagersFinance Hadean Ventures AS (Hadean Ventures) is a venture capital firm that manages alternative investment funds. The firm was founded by Ingrid Helene Teigland Akay in 2014 and is headquartered in Oslo, Norway.
7
| Subsidiary | Investment Managers | 7 |
TargED Biopharmaceuticals BV
 TargED Biopharmaceuticals BV BiotechnologyHealth Technology TargED Biopharmaceuticals BV is a Dutch company that develops biological drugs. The company is based in Utrecht, Netherlands. The company was founded by Coen Maas, Kristof Vercruysse, Marc van Moorsel, Steven de Maat. Kristof Vercruysse has been the CEO since incorporation.
3
| Holding Company | Biotechnology | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Roger Franklin
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Credit Suisse Securities (Europe) Ltd.
 Credit Suisse Securities (Europe) Ltd. Investment Banks/BrokersFinance Credit Suisse Securities (Europe) Ltd. (Credit Suisse Europe) is the Great Britain-based brokerage subsidiary of Credit Suisse Investment Holdings (UK), itself a subsidiary of Credit Suisse Group AG (SWX: CSGN) in Switzerland. The firm was founded in 1966 and formerly known as Credit Suisse First Boston (Europe) Ltd. Headquartered in London, Credit Suisse Europe arranges financing in international capital markets, provides financial advisory services and acts as a dealer in securities, derivatives and foreign exchange on a principal and agency basis for corporate and institutional investors. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity Analyst-Equity Analyst-Equity | |
JPMorgan Securities Plc
 JPMorgan Securities Plc Financial ConglomeratesFinance JPMorgan Securities Plc is a brokerage firm headquartered in London, UK. The firm was founded in 1992 and is a wholly-owned subsidiary of JP Morgan Capital Holdings Ltd., ultimately owned by JPMorgan Chase & Co. (NYSE: JPM) in the US. JPMorgan Securities provides market research, proprietary pricing data and analytics, and trade execution across multiple asset classes such as credit, equities and FX. They help institutional investors, traditional and alternative asset and fund managers, broker dealers and equity issuers meet the demands of changing markets. | Financial Conglomerates | Analyst-Equity Analyst-Equity Analyst-Equity Analyst-Equity Trading-Equity | |
| University of Bristol | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Lund | College/University | Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
Canaccord Genuity Ltd.
 Canaccord Genuity Ltd. Investment Banks/BrokersFinance Canaccord Genuity Ltd. (CGL) is the brokerage subsidiary of Canaccord Genuity Group, Inc. (TSE: CF). The firm is headquartered in London and was founded in 1983. CGL provides brokerage services to their clients. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity Analyst-Equity | |
Redburn (Europe) Ltd.
 Redburn (Europe) Ltd. Investment Banks/BrokersFinance Redburn (Europe) Ltd. (dba Redburn Atlantic) is an equity brokerage firm headquartered in London, UK. The firm was founded in 2003 by Jeremy Evans and Nick Glydon. They are a wholly owned subsidiary of Rothschild & Co. Continuation Holdings AG, ultimately owned by Rothschild & Co SCA. (EPA: ROTH) in France. Redburn Atlantic provides institutional investors with US and European equity research, trade execution and capital markets services. Their Execution Services division delivers high-touch sales trading and execution as well as low-touch execution and algorithmic solutions. The division also offers market structure and trading analytics. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity | |
Investec Bank Plc (Broker)
 Investec Bank Plc (Broker) Investment Banks/BrokersFinance Investec Bank Plc (Broker) (IBP) is the brokerage arm of Investec Bank Plc, itself a subsidiary of Investec Plc (LON: INVP) in Great Britain. Headquartered in London, IBP was founded in 1950 and they offer a full spectrum of brokerage services specifically tailored for corporate clients. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity Analyst-Equity | |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| OREXO AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Executive Officer | |
| Stockholm School of Economics | College/University | Graduate Degree Masters Business Admin Graduate Degree | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Director/Board Member Chief Operating Officer | |
Joh. Berenberg, Gossler & Co. KG (United Kingdom)
 Joh. Berenberg, Gossler & Co. KG (United Kingdom) Investment Banks/BrokersFinance Joh. Berenberg, Gossler & Co. KG (United Kingdom) (Berenberg-UK) is the Great Britain-based broker/dealer division of Joh. Berenberg, Gossler & Co. KG, a multinational full-service investment bank in Germany. Headquartered in London, Berenberg-UK was founded in 2003 and provides trading and brokerage services to institutional and corporate clients. | Investment Banks/Brokers | Analyst-Equity Director of Research - Equity | |
| London Business School | College/University | Graduate Degree Masters Business Admin | |
| London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| STAYBLE THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NatWest Markets Plc (Broker) | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| Stayble AB | Director/Board Member Director/Board Member | ||
| University of Gothenburg | College/University | Undergraduate Degree Corporate Officer/Principal | |
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Cormorant Pharmaceuticals AB
 Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Founder | |
| LIDDS AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
OBN (UK) Ltd.
 OBN (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services OBN (UK) Ltd. is a non-profit organization, which focuses on supporting and bringing together the UK’s life sciences companies, corporate partners and investors. The company is headquartered in Abingdon, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Peel Hunt LLP
 Peel Hunt LLP Investment Banks/BrokersFinance Peel Hunt LLP is an independent securities brokerage firm headquartered in London, UK. The firm was founded in 1989 as a market liquidity provider to retail and institutional investors. They provide bespoke dealing and execution services for institutional asset managers, registrars, private client wealth managers and private banks. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
| INITIATOR PHARMA A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Karolinska Institutet Innovations AB
 Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Financial Conglomerates | Chairman Director/Board Member | |
| University of Oslo | College/University | Doctorate Degree Undergraduate Degree | |
Numis Securities Ltd.
 Numis Securities Ltd. Investment Banks/BrokersFinance Numis Securities Ltd. is an institutional brokerage firm headquartered in London, UK. The firm was founded in 1988 and is a subsidiary of Numis Corp. Plc in (LON: NUM). Numis Securities serves as a corporate broker to several clients across all their sectors, ranging from FTSE 100 to FTSE small-cap companies and AIM-listed companies. | Investment Banks/Brokers | Director/Board Member Analyst-Equity | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| MENDUS AB | Biotechnology | Director/Board Member Director/Board Member | |
Hubsphere Ltd.
 Hubsphere Ltd. Packaged SoftwareTechnology Services Part of Carbon Guerrilla Ltd., Hubsphere Ltd. is a British software company that provides software solutions and supporting services. The company is based in London, UK. Hubsphere was acquired by Carbon Guerrilla Ltd. from Hubsphere SAS on March 21, 2012. | Packaged Software | Corporate Officer/Principal | |
| University of Cambridge | College/University | Undergraduate Degree | |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Clipperton Finance Ltd. | Analyst-Equity | ||
| The University of Edinburgh | College/University | Undergraduate Degree | |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chief Executive Officer |
Statistik
International
| Vereinigtes Königreich | 27 |
| Schweden | 23 |
| Dänemark | 2 |
| Norwegen | 2 |
Sektoral
| Finance | 21 |
| Health Technology | 14 |
| Consumer Services | 11 |
| Commercial Services | 4 |
| Technology Services | 3 |
Operativ
| Director/Board Member | 161 |
| Analyst-Equity | 150 |
| Corporate Officer/Principal | 68 |
| Independent Dir/Board Member | 41 |
| Chairman | 40 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Roger Franklin
- Unternehmensverbindungen
